News

Scalable Cloud-Based Solution Provides High Availability and IT Cost Predictability

ACRP and the ENACCT are pleased to announce the integration of key ENACCT products and services into the current ACRP professional development portfolio.

The pharmaceutical industry continues to outsource more clinical trials to contract research organizations each year...

With the help of Oracle Health Sciences Consulting, Santen migrated its legacy data and rolled out the Oracle Argus Cloud Service solution in 10 months.

The European Union has managed to snatch defeat from the jaws of opportunity once more!

Functional service provider arrangements, or FSPs, are evolving beyond the clinical data management tasks they were designed to streamline.

In the clinical development setting, most organizations are already working in an electronic world but still thinking in "paper."

Health technology assessment is a field of analysis that evaluates the medical, social, ethical, and economic implications of development, diffusion, and use of health technology.

The costs of drug development are increasing, driven in large part by increasing failure rates in all phases of clinical development.

Eurofins Central Laboratory is pleased to announce that is has achieved an important strategic milestone with the expansion and relocation of its US Central Laboratory Operations

Eurofins Central Laboratory announced the expansion and relocation of its US Central Laboratory Operations to the company's Pharma Services campus in Lancaster, PA.

Principal Investigators announced global availability of its online platform designed specifically to connect Medical Doctors with Pharma and R&D companies involved in clinical studies

The New and Easier Way to Find Patients and Begin Clinical Trials.

PAREXEL announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services

With the public release of physician payment data slated for September, the implications for medical and scientific communications are many.

PAREXEL announced it has acquired all of the outstanding equity securities of ATLAS Medical Services.

Is the FDA doing enough to incorporate the patient perspective in the drug review process?

AVERT Delivers Proven and Efficient Solution for Broad Assessment of Suicide Risk

The State of Oklahoma, Department of Mental Health and Substance Abuse Services will be implementing ERT's AVERT Suicide Risk Assessment

The mounting outrage over exorbitant prices for new medicines increases the importance of reducing the cost of biomedical product development.

An article that sets the stage for why improvements in the contract negotiations with sites has and needed to improve for the past two years.

The potential of comparative effective research in transforming healthcare remains untapped, but the opportunities are there.

Patient consent is important to stay on top of for many reasons.

The report of a joint initiative by the EMA and the EUnetHTA has been published.

The report of an initiative undertaken jointly by EMA and EUnetHTA to make regulators' reports about scientific assessments of medicines better usable by health technology assessment bodies, has been published.

More than three million NHS patients in England have taken part in research studies over the last six years supported by the National Institute for Health Research Clinical Research Network.

More than three million National Health Service patients in England have participated in research studies over the last six years.

RAPS has released the results of its biennial survey of the global healthcare regulatory profession.

The advent of Accountable Care Organizations is causing providers to rethink their legacy financial models as they seek to effectively quantify and understand the clinical or financial experience of their patients.

RAPS has released the results of its biennial survey of the global healthcare regulatory profession.